GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings
About GINWA ENTERPRISE (GROUP) INC.
Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 国金证券关于金花企业（集团）股份有限公司2025年募集资金存放、管理与实际使用情况的专项核查报告 | 2026-04-28 | Chinese | |
| 独立董事候选人声明与承诺（刘晓娟） | 2026-04-28 | Chinese | |
| 金花企业集团（股份）有限公司2025年内部控制评价报告 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司章程全文 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司2025年12月31日内部控制审计报告 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司独立董事2025年度述职报告（刘晓娟） | 2026-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40287209 | 国金证券关于金花企业（集团）股份有限公司2025年募集资金存放、管理与实际使用情况的专项核查报告 | 2026-04-28 | Chinese | ||
| 40287200 | 独立董事候选人声明与承诺（刘晓娟） | 2026-04-28 | Chinese | ||
| 40287192 | 金花企业集团（股份）有限公司2025年内部控制评价报告 | 2026-04-28 | Chinese | ||
| 40287183 | 金花企业（集团）股份有限公司章程全文 | 2026-04-28 | Chinese | ||
| 40287175 | 金花企业（集团）股份有限公司2025年12月31日内部控制审计报告 | 2026-04-28 | Chinese | ||
| 40287122 | 金花企业（集团）股份有限公司独立董事2025年度述职报告（刘晓娟） | 2026-04-28 | Chinese | ||
| 40287117 | 金花企业（集团）股份有限公司关于修订《公司章程》的公告 | 2026-04-28 | Chinese | ||
| 40287112 | 金花企业（集团）股份有限公司2025年度募集资金年度存放、管理与实际使用情况鉴证报告 | 2026-04-28 | Chinese | ||
| 40287030 | 金花企业（集团）股份有限公司独立董事2025年度述职报告（赵舸） | 2026-04-28 | Chinese | ||
| 40287022 | 金花企业（集团）股份有限公司董事会审计委员会对会计师事务所2025年度履行监督职责情况报告 | 2026-04-28 | Chinese | ||
| 40287016 | 金花企业（集团）股份有限公司董事会审计委员会2025年度履职报告 | 2026-04-28 | Chinese | ||
| 40287008 | 金花企业（集团）股份有限公司关于确认公司董事及高级管理人员2025年度薪酬及2026年度薪酬方案的公告 | 2026-04-28 | Chinese | ||
| 40286998 | 独立董事提名人声明与承诺（刘晓娟） | 2026-04-28 | Chinese | ||
| 40286989 | 金花企业（集团）股份有限公司2025年度非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-28 | Chinese | ||
| 40286949 | 金花企业（集团）股份有限公司关于2025年度拟不进行利润分配的公告 | 2026-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GINWA ENTERPRISE (GROUP) INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56468/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56468 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56468 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56468 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56468}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GINWA ENTERPRISE (GROUP) INC. (id: 56468)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.